Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,728 INR | -0.59% | -2.00% | -10.19% |
Apr. 08 | Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals | CI |
Apr. 08 | Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.19% | 3.44B | |
+24.35% | 653B | |
+25.67% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.92% | 233B | |
+5.13% | 201B | |
-9.98% | 193B | |
-6.47% | 144B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Nomura Adjusts Gland Pharma’s Price target to 2,236 Indian Rupees From 2,362 Rupees, Keeps at Neutral